Vaccine Roll-out

Jonathan Ashworth Excerpts

Thursday 21st January 2021 Commons Chamber

[Matt Hancock]

Typically, I have come forward at least once a week, and I am very happy to do that and to respond to questions at any time. I am very glad that the technology is working and I can do that while self-isolating at home, as I am now.

On the substance of the questions asked by my hon. Friend the Member for Bexhill and Battle (Huw Merriman), the first thing I would say is that I am absolutely delighted that there are new centres opening in Sussex—in Ticehurst village hall this week—so that the roll-out can reach all parts. I will consider the point that he makes about cohorts 5 to 9, which will need the first dose of the vaccine at the same point as we start the second dose for those who have been vaccinated from the start of January. When we restart with the second doses, it will be important to make sure that they are available as close as possible to the largely elderly population who will need them, and I will take away the point that he raises.

The challenge on the contract is tied in with the first and third of my hon. Friend’s questions. The challenge is essentially that we have a lumpy supply. The manufacturers are working incredibly hard to deliver the supply as fast as possible, and I pay tribute to them and their work. It is challenging, however, and therefore it is not possible to give certainty as far out as many GPs and those who are delivering on the ground would like. The worst thing would be to give false certainty. We do try to give information about what is coming next week, but until the supply smooths out, as I am sure it will over time, going further out than that would give false certainty. The worst thing would be to have GPs across the country booking in large numbers of people and having to reschedule those appointments unnecessarily.

I will take into account the point that the Oxford-AstraZeneca vaccine is easier to deliver in rural areas, and the request for some people to be able to do that. At the moment, however, we must use the contract that we have.

[Jonathan Ashworth (Leicester South) (Lab/Co-op)]

Yesterday I visited the vaccination centre at Leicester racecourse, and it was inspirational to see the joy on the faces of those who were vaccinated and the pride of the staff and volunteers doing the vaccination. The figure of 4.6 million is indeed welcome, and it is a reminder that when the NHS is put in charge and tasked with implementing a large-scale project across our communities, it gets on with it and delivers. The Secretary of State has a target to vaccinate care home residents by the end of the week. Will he update us on progress towards that target?

Today we have had the latest Imperial survey, and the findings are alarming. It is especially concerning that infection rates are so high in London, and yet London and the east of England appear to be behind the rest of the country on vaccine roll-out. Will he tell us what action is being taken to speed up vaccination across London and the east of England? The Imperial survey also highlights the disproportionate infection rates among key workers and those from black, Asian and minority ethnic backgrounds. Once the nine priority groups are vaccinated, is it the Secretary of State’s expectation that we will then move to prioritise key workers—teachers, police officers, firefighters, transport workers, supermarket staff—who are more exposed to the virus at the moment?

The Secretary of State will know that there are 11,000 community pharmacists. That could mean up to 30,000 pharmacists at the heart of delivering this vaccine. We should be using them not just because of the volumes of doses they can administer, but because they have years of experience of building trust and vaccine acceptability within hard-to-reach groups and minority ethnic communities. I was speaking to pharmacists this week in Dudley who were telling me this. They also, by the way, raised concerns about the wider supply of the consumables needed to administer the vaccine. Can he guarantee that there will be no delay or shortages in the delivery of this wider kit?

The new variants remind us that we have to go further and faster on vaccination and work harder to break transmission chains. Early analysis suggests the South African B1351 variant brings a reinfection risk that means vaccines may need to be redesigned. Has the Secretary of State got a contingency plan in place?

Finally, yesterday’s death numbers were truly horrific. Vaccination has to go hand in hand with measures to suppress this virus. That means further containment measures. Not everybody can work at home comfortably or isolate themselves. The system is still expecting families to go hungry to stop spreading infection. Can I urge the Secretary of State again to fix sick pay and give people proper financial support so that they can isolate and we can drive infection rates down?

[Matt Hancock]

I agree with the hon. Gentleman that the NHS is doing a great job, supported by so many people. In particular, I want to thank the volunteers who have stepped forward—tens of thousands of them—and are now working to deliver the vaccination programme alongside NHS staff and, of course, members of our armed forces. In fact, there are several Members of this House who are, as we speak, supporting vaccination in vaccination centres, and some of them are doing vaccinations themselves. I am very grateful to all the volunteers.

The hon. Gentleman raises the question of pharmacies and, absolutely, pharmacies are going to be incredibly important, especially for reaching into those communities that may be otherwise harder to reach. The NHS as a whole is highly respected and trusted in all communities of this country so is well placed to do that, and pharmacy colleagues within the NHS particularly so, because they are often the closest to their communities. As I have set out, we have opened 65 vaccination centres that are pharmacy-led this week, with more to come.

The hon. Gentleman asks about the residents of elderly care homes. I am delighted to say that 63% of residents in elderly care homes have now received the vaccination. That is a really significant increase over the last week. We are on track to deliver on our goal of vaccinating elderly care home residents by the end of this month, and I hope sooner than that.

Finally, the hon. Gentleman asks about the question of the need—potential need—for vaccine redesign if there is a new variant that is not effectively dealt with by these vaccines. Obviously, we are vigilant on that and keep it under close review. I am glad to say that the early indications are that the new variant is dealt with by the vaccine just as much as the old variant, but of course we are vigilant on the new variants we are seeing overseas. He mentioned the South Africa variant, and there is also a variant of concern that was first identified in Brazil, and of course we are vigilant on those matters, too.

What I would say in summary is that all of these things just support the need for everybody to follow the rules and stay at home. It is critical that everybody does their bit to try to stop the spread of this virus while we get the numbers under control and bring them down, thus protecting the NHS and getting this death toll down, because it is far too high.